CS logo
small CS logo
CH PAU - Service de Médecine interne et Maladies infectieuses

Pau, France
General hospital in Pau, Pyrénées-Atlantiques
4 Bd Hauterive, 64000 Pau

About CH PAU - Service de Médecine interne et Maladies infectieuses


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender

Clinical Trials at CH PAU - Service de Médecine interne et Maladies infectieuses


During the past decade, CH PAU - Service de Médecine interne et Maladies infectieuses conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Clinical Trials Sponsors and Collaborators



Clinical Trials Conditions at CH PAU - Service de Médecine interne et Maladies infectieuses


According to Clinical.Site data, the most researched conditions in "CH PAU - Service de Médecine interne et Maladies infectieuses" are "Infective Endocarditis" (2 trials). Many other conditions were trialed in "CH PAU - Service de Médecine interne et Maladies infectieuses" in a lesser frequency.

Clinical Trials Intervention Types at CH PAU - Service de Médecine interne et Maladies infectieuses


Most popular intervention types in "CH PAU - Service de Médecine interne et Maladies infectieuses" are "Drug" (2 trials) and "Procedure" (2 trials). Other intervention types were less common.
The name of intervention was led by "Amoxicillin" (1 trials), "Conventional IV treatment of staphylococci IE following European guidelines 2015 including cloxacilline, oxacilline,gentamicine,vancomycine,rifampicine" (1 trials), "Conventional IV treatment of streptococci/enterococci IE following European guidelines 2015 including amoxicillin, gentamicin, amicillin, vancomycin, penicillin G, ceftriaxone, netilmicin" (1 trials), "Levofloxacin" (1 trials) and "Rifampicin" (1 trials). Other intervention names were less common.

Clinical Trials Genders at CH PAU - Service de Médecine interne et Maladies infectieuses


The vast majority of trials in "CH PAU - Service de Médecine interne et Maladies infectieuses" are 2 trials for "All" genders.

Clinical Trials Status at CH PAU - Service de Médecine interne et Maladies infectieuses


Currently, there are NaN active trials in "CH PAU - Service de Médecine interne et Maladies infectieuses". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in CH PAU - Service de Médecine interne et Maladies infectieuses, undefined suspended trials, and undefined terminated clinical trials to date.
Out of the total trials that were conducted in CH PAU - Service de Médecine interne et Maladies infectieuses, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".